Medical Devices: Page

  • A photo shows Insulet Chief Medical Officer Trang Ly
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip
    Q&A

    Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

    Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.

    By • Aug. 27, 2024
  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Inari updates label of clot removal device linked to 6 deaths

    Inari recalled the catheter and revised instructions for use after reports of the device becoming entrapped or blocking patients’ lung arteries.

    By • Aug. 27, 2024
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers to grow PET imaging with purchase of Novartis assets

    Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.

    By • Aug. 27, 2024
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet expands Omnipod 5 pump to people with Type 2 diabetes

    The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.

    By • Aug. 26, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom prices first over-the-counter glucose monitor

    Known as Stelo, the device is intended for people who don’t take insulin and costs $89 per month.

    By • Aug. 26, 2024
  • A sign reading Food and Drug Administration is seen above a door to a government building.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Defibtech recalls chest compression device linked to patient death

    Customers are asked to return affected devices due to a problem in the motor that could stop compressions.

    By • Aug. 26, 2024
  • FDA headquarters with sign in foreground
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA seeks feedback on predetermined change control plans

    The guidance describes changes companies can make to medical devices without filing a new 510(k) or premarket approval supplement.

    By • Aug. 26, 2024
  • The lobby of Stryker's new headquarters building in Portage, Michigan, is pictured.
    Image attribution tooltip
    Retrieved from Stryker on August 23, 2024
    Image attribution tooltip

    Stryker to add back pain treatment with Vertos Medical buy

    Stryker’s latest purchase comes amid a pickup in medtech M&A, with Johnson & Johnson, Boston Scientific and Edwards Lifesciences all active this year.

    By • Aug. 23, 2024
  • An image of the Procept Biorobotics system against a white background.
    Image attribution tooltip
    Courtesy of Procept Biorobotics
    Image attribution tooltip

    Procept wins FDA clearance for updated prostate surgery robot

    Procept Biorobotics has added AI capabilities and switched to a single-use scope to support mass-market adoption.

    By • Aug. 22, 2024
  • Judges Or Auctioneer Gavel On The Dollar Cash Background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zoll to buy Vyaire’s ventilator business with $37M auction bid

    Vyaire Medical held a virtual auction of assets after filing for Chapter 11 bankruptcy protection in June.

    By • Aug. 21, 2024
  • U.S. Government Accountability Office
    Image attribution tooltip
    "Government Accountability Office Building" by kafka4prez is licensed under CC BY-SA 2.0
    Image attribution tooltip

    FDA’s plan to expand device surveillance faces challenges, GAO finds

    Funding issues and limited use of unique device identifiers are hurdles to expanding an FDA system to monitor medical device safety, the federal watchdog said.

    By • Aug. 21, 2024
  • A Marantz home entertainment system is pictured on a wooden table top with a city skyline at nighttime visible in the background through a window.
    Image attribution tooltip
    Retrieved from Masimo on August 20, 2024
    Image attribution tooltip

    Masimo’s consumer audio brands attract more suitors

    Negotiations with a potential joint venture partner will continue while Masimo initiates discussions with new parties that have expressed interest in the consumer audio business.

    By • Aug. 21, 2024
  • V-Wave's implantable device for heart failure is shown next to a dime.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J to buy heart failure implant maker V-Wave for up to $1.7B

    J&J has agreed to pay $600 million upfront for the private company as it works to expand its portfolio of cardiovascular devices.

    By • Aug. 20, 2024
  • Image attribution tooltip
    Edwards Lifesciences
    Image attribution tooltip

    Edwards continues M&A spree with Genesis’ TAVR tech

    Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.

    By • Aug. 19, 2024
  • Histosonics' Edison histotripsy system is pictured in an operating room.
    Image attribution tooltip
    Permission granted by Histosonics
    Image attribution tooltip

    Histosonics raises $102M for noninvasive treatment to destroy tumors

    Using sound waves to break down tumor tissue can offer patients with liver cancer an alternative to surgery, radiation and chemotherapy.

    By • Aug. 19, 2024
  • Two people wearing suits stand in between two people talking wearing white coats in a laboratory setting.
    Image attribution tooltip
    Erin Scott / U.S. White House. Retrieved from Flickr.
    Image attribution tooltip

    Biden pledges $150M for medical tech to improve cancer surgery

    Awards include funding for microscopy and imaging tools to help surgeons ensure all cancer is removed during a procedure.

    By • Aug. 16, 2024
  • A picture of Stereotaxis' GenesisX surgical robot against a white background.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis earns CE mark for new surgical robot

    CEO David Fischel said the platform, called GenesisX, is designed to address challenges hospitals have faced when installing the company’s earlier robotic systems.

    By • Aug. 15, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem warns iPhone app still draining insulin pump batteries

    Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected shutdowns.

    By • Aug. 15, 2024
  • A picture of the Neurostar chair
    Image attribution tooltip
    Permission granted by Neuronetics
    Image attribution tooltip

    Neuronetics inks Greenbrook merger to acquire treatment centers

    William Blair analysts said the deal changes Neuronetics’ profile “from device-centric to a device-service business operating brick-and-mortar facilities.” 

    By • Aug. 15, 2024
  • A person holds a phone that shows an image of a face with the prompt: "Does this emotion match the previous one?"
    Image attribution tooltip
    Retrieved from Otsuka Precision Health on August 14, 2024
    Image attribution tooltip

    Otsuka Precision Health launches first digital therapeutic for depression

    Intended to supplement medications, the six-week, app-based treatment will cost $50 on a cash-pay basis.

    By • Aug. 14, 2024
  • A person fits a tool in a robot arm while two other people wearing masks, caps and gloves stand around a hospital bed.
    Image attribution tooltip
    Retrieved from Globus Medical on August 14, 2024
    Image attribution tooltip

    Globus receives warning letter over spine navigation robot

    The FDA said Globus delayed reporting complaints about misplaced screws, despite information that “reasonably suggests” the Excelsius GPS system malfunctioned.

    By • Aug. 14, 2024
  • A windowed building surrounded by trees with a sign "Baxter" in front
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Baxter agrees to sell kidney care unit to Carlyle for $3.8B

    Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said.

    By • Aug. 13, 2024
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins FDA approval for asleep deep brain stimulation

    Medtronic said Monday it is the first company to receive FDA approval to offer DBS surgery while a patient is asleep or awake.

    By • Aug. 13, 2024
  • A picture of Breas Medical's Vivo 45 LS ventilator device against a white background.
    Image attribution tooltip
    Retrieved from Breas Medical on August 12, 2024
    Image attribution tooltip

    Breas Medical flags risk of formaldehyde exposure in ventilators

    Testing showed the potential for short-term exposure to elevated levels of formaldehyde under specific conditions.

    By • Aug. 12, 2024
  • Professional photo of Bryan Hanson
    Image attribution tooltip
    Courtesy of 3M
    Image attribution tooltip

    Solventum raises earnings forecast after first independent quarter

    Four months after separating from 3M, CEO Bryan Hanson told investors on Solventum’s first earnings call that “a lot could have gone wrong, and it didn’t.”

    By • Aug. 9, 2024